Current Pharmaceutical Design

ISSN: 1381-6128 - Volume 14, 36 Issues, 2008

Editor-in-Chief:

William A. Banks
School of Medicine
St. Louis University
St. Louis, MO
USA

Executive Editors:

Atta-ur-Rahman, FRS (H.E.J Research Institute of Chemistry, Karachi, Pakistan)
Matthew Honan (Bentham Science Publishers)

Editorial Advisory Board:

Kenneth L. Audus (The University of Kansas, Lawrence, KS, USA)
Scott A. Biller (Novartis Institutes for BioMedical Research, Cambridge, MA, USA)
Steven J. Brickner (Pfizer, Groton, CT, USA)
D. Allan Butterfield (University of Kentucky, Lexington, KY, USA)
Giovanni Capranico (Istituto Nazionale Tumori, Milan, Italy)
Craig E. Caufield (Wyeth-Ayerst Research, Princeton, NJ, USA)
Daniel T.W. Chu (Chiron Corporation, Emeryville, CA, USA)
Stevan W. Djuric (Abbott Laboratories, Abbott Park, IL, USA)
Errol B. De Souza (Neurocrine Biosciences, San Diego, CA, USA)
Elisabeth G.E. De Vries (Univ. of Groningen, Groningen, Netherlands)
Annette M. Doherty (Pfizer Global R & D, Sandwich, Kent, UK)
Roland E. Dolle (Pharmacopeia, Inc., Princeton, NJ, USA)
Catherine L. Farrell (Amgen, Inc.,Thousand Oaks, CA, USA)
Roger M. Freidinger (Merck Res. Laboratories, West Point, PA, USA)
Donald R. Gehlert (Lilly Research Laboratories, IN, USA)
Nigel H. Greig (National Institutes of Health, Baltimore, MD, USA)
James M. Hamby (Parke-Davis, Pharm. Res. Ann Arbor, MI, USA)
Emilio Jirillo (Bari University, Bari, Italy)
Graham Johnson (Bristol-Myers Squibb, CT, USA)
Abba J. Kastin (Pennington Biomedical Res. Ctr, Baton Rouge, LA, USA)
Keith W. Kelley (University of Illinois, Urbana, IL, USA)
Marlys Koschinsky (Queen's University, Kingston, Canada)
Kit S. Lam (UC Davis Cancer Center, Sacramento, CA, USA)
Gregory YH Lip (University Department of Medicine, City Hospital, Birmingham, UK)
Hans Marquardt (Universität Hamburg, Hamburg, Germany)
Dimitri P. Mikhailidis (Royal Free Hospital, London, UK)
John E. Morley (St. Louis Univ. Health Sciences Center, St. Louis, MO, USA)
John H. Musser (Glycomed, Alameda, CA, USA)
Weihong Pan (Pennington Biomedical Research Center, Baton Rouge, LA, USA)
Martin Petkovich (Queen's University, Kingston, Canada)
Waldemar Priebe (University of Texas, Houston, TX, USA)
Andrew V. Schally (VAMC, New Orleans, LA, USA) Nobel laureate
George J. Schroepfer Jr. (Rice University, Houston, TX, USA)
Linus L. Shen (Abbott Laboratories, Abbott Park, IL, USA)
Seiji Shioda (Showa Univ. Sch. of Medicine, Shinagawa-ku, Tokyo, Japan)
Jeffrey D. Shmitt (Mol. Design & IT Group, North Carolina, USA)
Claudio Soto (University of Texas Medical Branch, Galveston, TX 77555, USA)
Claudiu T. Supuran (University of Florence, Firenze, Italy)
Tetsuya Terasaki (Graduate School of Pharmaceutical, Tohoku University, Sendai, Japan)
Nese Tuncel (Osmangazi University, Eskisehir- Turkey)
Franco Zunino (Istituto Nazionale Tumori, Milan, Italy)

Executive Guest Editors:

Anti-Infective Agents
Mitchell A. Avery (USA)
Fatima Z. Basha (USA)
Vassil St. Georgiev (USA)

Anti-Cancer Drugs
E.S. Bergmann-Leitner (USA)

Peptide Radiopharmaceuticals
Jay Elliot Blum (USA)

Proteases and Protease Inhibitors
Boris Turk (Slovenia)

Anti-Angiogenesis Agents
Maurizio Botta (Italy)
Cezary Marcinkiewicz (USA)

Development of Cytokines for Use in Treatment of Blood Disorders
Ken Bradstock (Australia)

COX-II Inhibitors
Angel Lanas Arbeloa (Spain)
Peter Brooks (Australia)

Anti-Cancer Agents
Giovanni Capranico (Italy)
I. Niculescu-Duvaz (UK)
Alan P. Kozikowski (USA)
Maurizio Pellecchia (USA)

Enzyme/Protease Inhibitors
Nestor Omar Concha (USA)

Radiolabelled Compounds for Drug Discovery and Development
G.J.R. Cook (UK)

Radiopharmaceuticals in Drug Discovery and Development
Michael Kassiou (Australia)

Neuropeptide-based Drug Design
Illana Gozes (Israel)

Analgesic Drug Design and Discovery
Gurmit Grewal (USA)

Pharmacophore Elucidation & Their Use in Drug Design
Salvatore Guccione (Italy)

Nitric Oxide in Drug Design & Discovery
D. Hadjipavlou-Litina (Greece)

Analgesic Drug Design
Tomoki Nishiyama (Japan)

Anti-Inflammatory and Anti-Allergy Agents
Milton John Kiefel (Australia)

Allergy-Asthma
Jan Lotvall (Sweden)

Recent Advances in Developmental Toxicology
Gian Mario Tiboni (Italy)

Protease Inhibitors
Robert W. Marquis (USA)
Vicki L. Nienaber (USA)

Applications of ACE Inhibitors and A2 Receptor Blockers
Agostino Molteni (USA)

Osteoporosis
Paul Morley (Canada)

Purine Receptors as Targets for Future Drugs
Christa E. Mueller (Germany)

DNA Topoisomerases as Targets for Anti-cancer Drugs
Neil Osheroff (USA)

HIV Drug Design (Anti-HIV Agents)
Keykavous Parang (USA)

Tumour Selective Drug Activation
Laurence H. Patterson (UK)

Bactericidal Peptides
Antonio Pellegrini (Switzerland)

Cardiovascular and Hematological Agents
Ho-Sam Ahn (USA)
Johann Wolfgang Auer (Austria)
Makoto Katoh (Japan)
Eva Lonn (Canada)

Enzyme Inhibition
Michel Salzet (France)

Autoimmune Diseases
W. Sibrowski (Germany)
D. Stahl (Germany)

PET and SPECT in Drug Design
Aren van Waarde (Netherlands)

Endocrine & Metabolic Agents
Wayne L. Cody (USA)
Allan Wagman (USA)

Obesity Drug Design
Christian Weyer (USA)

Central Nervous System Agents
David W. Smith (USA)
Joseph P. Yevich (USA)

Potential Therapeutic Agents for Parkinson’s Disease
Masato Asanuma (Japan)

Genomics of Antibacterial & Antifungal Agents
John F. Barrett (USA)

Kinase and Phosphatase Drug Discovery and Design
Dirksen Bussiere (USA)

Anti-Thrombotics
Dermot Cox (Ireland)

Trypanosomiasis and Leishmaniasis
Wanderley de Souza (Brasil)

Death Receptor Ligands
E.G. Elisabeth de Vries (The Netherlands)

Antimetabolic Agents
Galal Hamza Elgemeie (Egypt)

Cognitive Impairment and Dementia
med. Bernd Ibach (Germany)

Antihypertensive drugs
Gregory YH -Lip (UK)

Infectious Disease – Drug Delivery to Treat
Shigefumi Maesaki (Japan)

Angiogenesis Agents
Cezary Marcinkiewicz (USA)

Medical Treatment of Head Injury
Maria Mataro (Spain)

Antithrombotic drug design
Hiroyuki Matsuno (Japan)

Antihypertensives
Trefor Morgan (Australia)

Cytokines and Anti-cytokines
Atsushi Oda (Japan)

G Protein-Coupled Receptor Drug Targets
Patrick Sexton (Australia)
Arthur Christopoulos (Australia)

Glutamate Receptor
Sandor Solyom (Hungary)

Therapeutics for Protein Misfolding Diseases
Claudio Soto (Switzerland)

Peptides and Peptidomimetics as Anti-cancer Therapeutics
Nadya Tarasova (USA)

Nitric Oxide in Reproduction
Gian Mario Tiboni (Italy)

Regulatory Peptides
Nese Tuncel (Turkey)

Antihypertensive Agents
Jiguang Wang (Belgium)

Drugs in Interventional Cardiology
Peter W. Radke (Germany)

Transplantation - Anti-Rejection Agents
Markus Richter (Germany)

Obesity Drug Design
J.C. Russell (Canada)

Cancer Vaccine and Immunotherapy
Farid Saleh (Kuwait)

Prebiotics and Probiotics Delivering Therapeutics as Dietary Components
Colum Dunne (Ireland)

Recent Advances in Antiviral Agents
Shin-Ru Shih (Taiwan)

Computational Biology and Drug Design
Xiaoqin Huang (USA)

Antidepressant Drug Design
Lee E. Schechter (USA)

HIV Entry Inhibitors
Shibo Jiang (USA)

Direct Thrombin Inhibitors and Synthetic F Xa Inhibition
Giuseppe G. Nenci (Italy)

Spinal Cord Injury and Repair
Weihong Pan (USA)

Current trends in the treatment of supraventricular Tachicardia in Pediatric age
Giuseppe Barbaro (Italy)

Carbonic anhydrases as drug targets
Claudiu T. Supuran (Italy)

Cell Adhesion Molecules: Function, Drug-Design and Biomaterials
Seetharama D.S. Jois (USA)